Found: 108
Select item for more details and to access through your institution.
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Cancer/testis antigens can be immunological targets in clonogenic CD133<sup>+</sup> melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1635, doi. 10.1007/s00262-009-0672-0
- By:
- Publication type:
- Article
IL-21 induces in vivo immune activation of NK cells and CD8<sup>+</sup> T cells in patients with metastatic melanoma and renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1439, doi. 10.1007/s00262-008-0479-4
- By:
- Publication type:
- Article
Peripheral Primitive Neuroectodermal Tumor Arising from the Seminal Vesicle.
- Published in:
- Urologia Internationalis, 2008, v. 80, n. 2, p. 212, doi. 10.1159/000112616
- By:
- Publication type:
- Article
The SUB‐urothelial DUrvalumab InjEction‐1 (SUBDUE‐1) trial: first‐in‐human trial in patients with bladder cancer.
- Published in:
- BJU International, 2024, v. 134, n. 2, p. 283, doi. 10.1111/bju.16325
- By:
- Publication type:
- Article
Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management.
- Published in:
- BJU International, 2024, v. 133, p. 7, doi. 10.1111/bju.16273
- By:
- Publication type:
- Article
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non‐clear‐cell renal cell carcinoma.
- Published in:
- BJU International, 2024, v. 133, p. 57, doi. 10.1111/bju.16190
- By:
- Publication type:
- Article
Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?
- Published in:
- BJU International, 2023, v. 132, n. 2, p. 146, doi. 10.1111/bju.16086
- By:
- Publication type:
- Article
Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?
- Published in:
- BJU International, 2023, v. 132, n. 2, p. 146, doi. 10.1111/bju.16086
- By:
- Publication type:
- Article
Impacts of the COVID‐19 pandemic on early detection of prostate cancer in Australia.
- Published in:
- BJU International, 2021, v. 128, p. 6, doi. 10.1111/bju.15631
- By:
- Publication type:
- Article
ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901)
- Published in:
- BJU International, 2021, v. 128, n. 5, p. 642, doi. 10.1111/bju.15491
- By:
- Publication type:
- Article
A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial protocol
- Published in:
- BJU International, 2021, v. 128, p. 9, doi. 10.1111/bju.15365
- By:
- Publication type:
- Article
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup>Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol).
- Published in:
- BJU International, 2021, v. 128, n. 3, p. 331, doi. 10.1111/bju.15384
- By:
- Publication type:
- Article
Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer.
- Published in:
- BJU International, 2019, v. 124, p. 50, doi. 10.1111/bju.14797
- By:
- Publication type:
- Article
TheraP: a randomized phase 2 trial of <sup>177</sup>Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603).
- Published in:
- BJU International, 2019, v. 124, p. 5, doi. 10.1111/bju.14876
- By:
- Publication type:
- Article
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non‐malignant prostate epithelial cells.
- Published in:
- BJU International, 2019, v. 123, p. 27, doi. 10.1111/bju.14695
- By:
- Publication type:
- Article
Management of patients with advanced prostate cancer in the Asia Pacific region: 'real‐world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.
- Published in:
- BJU International, 2019, v. 123, n. 1, p. 22, doi. 10.1111/bju.14489
- By:
- Publication type:
- Article
Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross‐sectional population‐based study.
- Published in:
- BJU International, 2018, v. 122, p. 50, doi. 10.1111/bju.14585
- By:
- Publication type:
- Article
Good clinical practice can and must include comparative effectiveness research.
- Published in:
- BJU International, 2018, v. 122, p. 7, doi. 10.1111/bju.14590
- By:
- Publication type:
- Article
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.
- Published in:
- BJU International, 2017, v. 119, p. 55, doi. 10.1111/bju.13873
- By:
- Publication type:
- Article
Patterns of care for metastatic renal cell carcinoma in Australia.
- Published in:
- BJU International, 2015, v. 116, p. 36, doi. 10.1111/bju.13176
- By:
- Publication type:
- Article
The Australian and New Zealand Urogenital and Prostate ( ANZUP) Cancer Trials Group - a new co-operative cancer trials group in genitourinary oncology.
- Published in:
- BJU International, 2015, v. 115, n. 6, p. 856, doi. 10.1111/bju.12925
- By:
- Publication type:
- Article
Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors.
- Published in:
- BMC Medical Genomics, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1755-8794-6-40
- By:
- Publication type:
- Article
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00570-x
- By:
- Publication type:
- Article
Treating cancer.
- Published in:
- Medical Journal of Australia, 1999, v. 170, n. 3, p. 137, doi. 10.5694/j.1326-5377.1999.tb127687.x
- By:
- Publication type:
- Article
Characterization of an Estrogen Receptor α-Selective <sup>18</sup> F-Estradiol PET Tracer.
- Published in:
- World Journal of Nuclear Medicine, 2024, v. 23, n. 3, p. 153, doi. 10.1055/s-0044-1786518
- By:
- Publication type:
- Article
Lytic effects of water on cancer cells: Implications for post‐operative irrigation.
- Published in:
- ANZ Journal of Surgery, 2022, v. 92, n. 1, p. 157, doi. 10.1111/ans.17145
- By:
- Publication type:
- Article
Continuous bladder irrigation after transurethral resection of non‐muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review.
- Published in:
- ANZ Journal of Surgery, 2021, v. 91, n. 12, p. 2592, doi. 10.1111/ans.16740
- By:
- Publication type:
- Article
Compliance with follow‐up for patients with stage 1 testicular germ cell tumour.
- Published in:
- ANZ Journal of Surgery, 2021, v. 91, n. 1, p. 184, doi. 10.1111/ans.16114
- By:
- Publication type:
- Article
Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes.
- Published in:
- ANZ Journal of Surgery, 2015, v. 85, n. 7/8, p. 535, doi. 10.1111/ans.12772
- By:
- Publication type:
- Article
Metastatic basal cell carcinoma: rapid symptomatic response to Cisplatin and Paclitaxel.
- Published in:
- ANZ Journal of Surgery, 2004, v. 74, n. 8, p. 704, doi. 10.1111/j.1445-1433.2004.03130.x
- By:
- Publication type:
- Article
The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium.
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 4, p. 664, doi. 10.1002/(SICI)1097-0215(19970807)72:4<664::AID-IJC19>3.0.CO;2-B
- By:
- Publication type:
- Article
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221092486
- By:
- Publication type:
- Article
Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221086827
- By:
- Publication type:
- Article
Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predictors of new‐onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population‐based analysis.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 7, p. 1597, doi. 10.1002/jso.25037
- By:
- Publication type:
- Article
An Open-Label Extension Study to Evaluate Safety and Efficacy of Pazopanib in Patients with Advanced Renal Cell Carcinoma.
- Published in:
- Oncology, 2014, v. 87, n. 6, p. 342, doi. 10.1159/000366227
- By:
- Publication type:
- Article
Xenografting Tumour beneath the Renal Capsule Using Modern Surgical Equipment.
- Published in:
- European Surgical Research, 2006, v. 38, n. 3, p. 340, doi. 10.1159/000094093
- By:
- Publication type:
- Article
The role of mindfulness in distress and quality of life for men with advanced prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET.
- Published in:
- Asia Oceania Journal of Nuclear Medicine & Biology, 2014, v. 2, n. 1, p. 3
- By:
- Publication type:
- Article
Experiences of participants in a clinical trial of a novel radioactive treatment for advanced prostate cancer: A nested, qualitative longitudinal study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0276063
- By:
- Publication type:
- Article
The contribution of multiparametric pelvic & whole body MR to interpretation of <sup>18</sup>F-fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.225185
- By:
- Publication type:
- Article
Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of <sup>18</sup>F-Fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1253, doi. 10.2967/jnumed.118.225185
- By:
- Publication type:
- Article
Assessment of Simplified Methods for Quantification of <sup>18</sup>F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1221, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
Prospective, Multisite, International Comparison of <sup>18</sup>F-Fluoromethylcholine PET/CT, Multiparametric MRI, and <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 6, p. 794, doi. 10.2967/jnumed.118.220103
- By:
- Publication type:
- Article
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 10, p. 1516, doi. 10.2967/jnumed.117.206490
- By:
- Publication type:
- Article
Flt3 ligand expands CD4<sup>+</sup> Fox P3<sup>+</sup> regulatory T cells in human subjects.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 2, p. 533, doi. 10.1002/eji.201242603
- By:
- Publication type:
- Article
A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048424
- By:
- Publication type:
- Article
A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0044707
- By:
- Publication type:
- Article